SARCOPENIA IS A KEY DETERMINANT MARKER OF LEAN MASLD: A COMPARATIVE ANALYSIS OF CLINICAL PROFILE, BODY COMPOSITION BY DEXA, AND MUSCLE STRENGTH IN LEAN, OVERWEIGHT, AND OBESE MASLD PATIENTS Marcella Motta Lucindo Duarte; Fernanda B.V. Coelho; Daniele Helena Faray Cortez da Silva; Sebastião Mauro Bezerra Duarte; Renato Gama Ribeiro Leite Altikes; Patrícia Momoyo Yoshimura Zitelli; José Tadeu Stefano; Hamilton Roschel; Bruno Gualano; Mario Guimarães Pessoa; Claudia P. Oliveira;

PERFORMANCE OF NON-INVASIVE TESTS (NITS) AND PREDICTORS OF OUTCOMES IN PATIENTS WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD) FROM LATIN AMERICA AND NORTH AMERICA Zobair Younossi; Leyla de Avila; Claudia P. Oliveira; Cristiane Villela-Nogueira; Marlen Ivon Castellanos Fernandez; Adrian Carlos Gadano; Marco Antonio Arrese Jimenez; Naim Alkhouri; Winston Dunn; Giada Sebastiani; Luis Antonio Diaz Piga; Brian Pearlman; Juan Pablo Arab; Rida Nadeem; Felice Cinque; Nicholas Dunn; Licet Gonzalez Fabian; Ahmed Almohsen; Nathalie Leite; Ethan Friend; Chencheng Xie; Ashwani Singal; Nadge Gunn; Brian Lam; Andre Racila; Maria Stepanova; Mário Guimarães Pessôa;

DIFFERENT LIPIDOMIC SIGNATURE IN EXTRACELLULAR VESICLES IN PATIENTS WITH MASLD- HCC: ANALYSIS OF DIFFERENT STAGES OF MASLD Mario Reis Alvares-da-Silva; Melina Keingeski Belén; Larisse Longo; Bruno de Souza Basso; Jose Tadeu Stefano; Claudia Pinto Oliveira; Carolina Uribe-Cruz; Juan Pablo Arab Verdugo;